Lipella - LIPO Net Assets per Single Share

Graphic logo of Lipella Pharmaceuticals (LIPO)

Lipella Pharmaceuticals (LIPO) plans to generate profit by implementing targeted treatment methods for urological pathologies. The book value per share reflects asset dynamics, where the 1.60 level serves as a critical benchmark. The company is repurposing established drugs for local application in an effort to minimize side effects. However, a narrow development focus in the early stages creates a high dependency on test results and external investments.

Lipella Pharmaceuticals Inc (LIPO): Share Book Value from 04/28/2023 to 07/19/2025

lipella.com - analytical breakdowns and key metrics (LIPO)

- price and consensus price forecast:
Price Chart Lipella|LIPO - Forecast Levels Chart
- market capitalization data:
Market Value Lipella Pharmaceuticals, Inc.|LIPO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Lipella Pharmaceuticals|LIPO - Net Asset Value|Market Capitalization to Book Value Ratio lipella.com|LIPO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Lipella Pharmaceuticals|LIPO - Long-Term Debt to Capital|Short-Term Debt to Equity Lipella Pharmaceuticals, Inc.|LIPO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Lipella Pharmaceuticals, Inc.
Fundamental company valuation:Lipella - LIPO
Manufactured products of Lipella Pharmaceuticals, Inc.

Equity analysis allows for the separation of fundamentally stable businesses from speculative assets by measuring the residual value of net assets per share after deducting all liabilities. For Lipella Pharmaceuticals (LIPO), which utilizes contract manufacturing and R&D laboratories, the net asset value per share confirms the company's ability to maintain its financial foundation without excessive capital expenditures on plants.

Competitors of Lipella Pharmaceuticals (LIPO)

Net Assets per Single Share Haleon Group|KVUE: Share Book Value|Net Assets per Single Share VRNA|MENS (jyongbio.com) - Net Asset Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|MindWalk Holdings (HYFT) - Net Assets per Single Share|Accounting Value of a Share ABVC (abvcpharma.com)|Net Assets per Single Share Cumberland Pharmaceuticals Inc. CPIX|Net Assets per Single Share Quantum BioPharma Ltd. QNTM|Book Value per Share FGEN (FibroGen Corp)|TELO: Net Assets per Share|Net Assets per Single Share ranitherapeutics.com (RANI)|Synergy CHC (SNYR) - Share Book Value|Book Value per Share RLYB (Rallybio Corp)|Net Asset Value per Share LEXX|Net Assets per Single Share Pulmatrix Corp (PULM)|Net Assets per Single Share PTHL (ftzy.com.cn)|Net Assets per Single Share Aptorum Group APM|Net Assets per Single Share lyratherapeutics.com LYRA|Impact BioMedical Inc - Book Value per Share|TNF Pharmaceuticals (TNFA) - Book Value per Share|Accounting Value per Share cbdmd.com YCBD|PRFX (PainReform Corp) - Accounting Value of a Share|Net Assets per Single Share Altamira Therapeutics Ltd CYTO|Share Book Value optinose.com|Pieris Pharmaceuticals, Inc. (PIRS) - Book Value per Share|Accounting Value of a Share Procaps Group (PROC)|Book Value per Share PTPI (Petros)|Qilian International Corp - Book Value per Share|Net Assets per Single Share Acelyrin, Inc. (SLRN)|TFFP: Accounting Value of a Share